Department of Neurology (all authors) and the Evelyn F. McKnight Brain Institute (Sacco, Rundek), University of Miami; Department of Neurology, Jackson Memorial Hospital, Miami (Sobczak, Swafford, Samano, Kottapally, Merenda, O'Phelan, Romano, Sacco, Rundek, Alkhachroum).
J Neuropsychiatry Clin Neurosci. 2023 Summer;35(3):256-261. doi: 10.1176/appi.neuropsych.20220126. Epub 2023 Jan 30.
Limited data are available on posttraumatic stress symptoms (PTSS) among COVID-19 survivors. This study aimed to contribute to this knowledge base.
PTSS among COVID-19 survivors who had been hospitalized were investigated. Patients were identified as COVID-19 positive at hospital admission. COVID-19 survivors were surveyed with the Posttraumatic Stress Disorder Checklist (PCL-5) between March and October 2020 at 5- and 12-month postdischarge follow-up points.
Of 411 patients, 331 (81%) survived to hospital discharge. Of these survivors, 83 (25%) completed the PCL-5 at the 5-month follow-up. Of those patients, 12 (14%) screened positive for PTSS. At the 12-month follow-up, four of eight patients remained PTSS positive. Mean age of follow-up participants was 62±15 years; 47% were women, 65% were White, and 63% were Hispanic. PTSS-positive patients were predominantly non-White (67% vs. 30%, p=0.02), and although the differences were not statistically significant, these patients tended to be younger (56 vs. 63 years, p=0.08) and have shorter intensive care unit stays (2.0 vs. 12.5 days, p=0.06). PTSS-positive and PTSS-negative groups did not differ significantly in prehospitalization neurological diagnoses (11% vs. 8%), psychiatric diagnoses (17% vs. 21%), and intensive care admission status (25% vs. 25%). More patients in the PTSS-positive group had returned to the emergency department (50% vs. 14%, p<0.01) and reported fatigue at follow-up (100% vs. 42%, p<0.001). In the multivariate logistic regression model, non-White race (OR=11, 95% CI=2-91) and returning to the emergency department (OR=19, 95% CI=3-252) were associated with PTSS-positive status.
PTSS were twice as common among hospitalized COVID-19 survivors than among those in the general population.
关于 COVID-19 幸存者的创伤后应激症状(PTSS),目前数据有限。本研究旨在为此提供相关知识基础。
调查了因 COVID-19 住院的幸存者的 PTSS。患者在住院时被确定为 COVID-19 阳性。COVID-19 幸存者在出院后 5 个月和 12 个月的随访点,通过创伤后应激障碍检查表(PCL-5)进行调查。
411 名患者中,有 331 名(81%)存活至出院。在这些幸存者中,有 83 名(25%)在 5 个月的随访中完成了 PCL-5。在这些患者中,有 12 名(14%)筛查出 PTSS 阳性。在 12 个月的随访中,8 名患者中有 4 名仍为 PTSS 阳性。随访参与者的平均年龄为 62±15 岁;47%为女性,65%为白人,63%为西班牙裔。PTSS 阳性患者主要为非白人(67% vs. 30%,p=0.02),虽然差异无统计学意义,但这些患者的年龄较小(56 岁 vs. 63 岁,p=0.08),且 ICU 住院时间较短(2.0 天 vs. 12.5 天,p=0.06)。PTSS 阳性组和 PTSS 阴性组在住院前的神经系统诊断(11% vs. 8%)、精神科诊断(17% vs. 21%)和 ICU 入院状态(25% vs. 25%)方面无显著差异。PTSS 阳性组中有更多的患者返回急诊科(50% vs. 14%,p<0.01),并在随访时报告疲劳(100% vs. 42%,p<0.001)。在多变量逻辑回归模型中,非白人种族(OR=11,95%CI=2-91)和返回急诊科(OR=19,95%CI=3-252)与 PTSS 阳性状态相关。
COVID-19 住院幸存者的 PTSS 发生率是普通人群的两倍。